Physician profile
Kory Jones
NPI 1033235627
$1,515.28
in general payments reported to CMS, 2019-2025
30 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $49.91 · 2021: $110 · 2022: $226 · 2023: $242 · 2024: $301 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $276.22 | 2023-2025 | Plasmablade(Tm), Endoflip |
| Myriad Genetic Laboratories, INC. | $267.42 | 2021-2025 | Myrisk |
| Intuitive Surgical, INC. | $133.87 | 2019-2022 | |
| Heron Therapeutics, INC. | $65.98 | 2021-2022 | |
| Allergan, INC. | $64.33 | 2019 | |
| Innocoll Pharmaceuticals Limited | $61.16 | 2021-2022 | |
| Abbvie INC. | $58.24 | 2023 | |
| Puma Biotechnology, INC. | $42.51 | 2019 | |
| Smith+Nephew, INC. | $41.41 | 2019-2023 | Pico 7 |
| Tactile Systems Technology INC | $38.42 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Shire North American Group INC | $36.53 | 2019 | |
| Tela Bio, INC. | $34.15 | 2019 | |
| Teleflex LLC | $33.61 | 2022-2023 | Titan Sgs Standard Gastric Stapler |
| Endo Pharmaceuticals INC. | $30.95 | 2019-2020 | |
| Incyte Corporation | $28.55 | 2025 | Jakafi |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $27.06 | 2022 | |
| Stemline Therapeutics INC. | $26.01 | 2025 | Orserdu |
| Regeneron Healthcare Solutions, INC. | $24.61 | 2025 | Lynozyfic |
| Merck Sharp & Dohme LLC | $24.48 | 2024 | Lynparza, Keytruda |
| Azurity Pharmaceuticals, INC. | $22.61 | 2025 | Danziten |
| Davol INC. | $22.38 | 2025 | Arista |
| Biom'Up France Sas | $21.62 | 2021 | |
| Cardinal Health 414 LLC | $21.50 | 2025 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Kerecis Limited | $19.70 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| W. L. Gore & Associates, INC. | $18.76 | 2022 | |
| Stryker Corporation | $17.31 | 2019 | |
| Endomagnetics LTD | $16.89 | 2021 | |
| Olympus America INC. | $14.05 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $12.61 | 2020 | |
| Hologic INC | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kory Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.